Physician profile
Michael D Wagner
NPI 1043217797
$664.20
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $230 · 2021: $119 · 2024: $26.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $268.55 | 2019-2021 | |
| Mylan Specialty L.P. | $96.55 | 2019-2020 | |
| Circassia INC. | $76.52 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $71.19 | 2020 | |
| Glaxosmithkline, LLC. | $42.98 | 2019-2021 | |
| Advanced Respiratory, INC | $27.60 | 2019 | |
| Lightforce Orthodontics, INC. | $26.25 | 2024 | |
| Abbott Laboratories | $24.41 | 2020 | |
| Grifols USA, LLC | $19.34 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.